Ethical considerations in adherence research

Nupur U Patel,1 Blake A Moore,1 Rebekah F Craver,2 Steven R Feldman1,2 1Department of Dermatology, Center for Dermatology Research, 2Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA Abstract: Poor adherence to treatment is a common cause of medi...

Full description

Bibliographic Details
Main Authors: Patel NU, Moore BA, Craver RF, Feldman SR
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/ethical-considerations-in-adherence-research-peer-reviewed-article-PPA
id doaj-c5944662804244668010fb4c169aaf76
record_format Article
spelling doaj-c5944662804244668010fb4c169aaf762020-11-24T22:29:02ZengDove Medical PressPatient Preference and Adherence1177-889X2016-12-01Volume 102429243530332Ethical considerations in adherence researchPatel NUMoore BACraver RFFeldman SRNupur U Patel,1 Blake A Moore,1 Rebekah F Craver,2 Steven R Feldman1,2 1Department of Dermatology, Center for Dermatology Research, 2Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA Abstract: Poor adherence to treatment is a common cause of medical treatment failure. Studying adherence is complicated by the potential for the study environment to impact adherence behavior. Studies performed without informing patients about adherence monitoring must balance the risks of deception against the potential benefits of the knowledge to be gained. Ethically monitoring a patient’s adherence to a treatment plan without full disclosure of the monitoring plan requires protecting the patient’s rights and upholding the fiduciary obligations of the investigator. Adherence monitoring can utilize different levels of deception varying from stealth monitoring, debriefing after the study while informing the subject that some information had been withheld in regard to the use of adherence monitoring (withholding), informed consent that discloses some form of adherence monitoring is being used and will be disclosed at the end of the study (authorized deception), and full disclosure. Different approaches offer different benefits and potential pitfalls. The approach used must balance the risk of nondisclosure against the potential for confounding the adherence monitoring data and the potential benefits that adherence monitoring data will have for the research subjects and/or other populations. This commentary aims to define various methods of adherence monitoring and to provide a discussion of the ethical considerations that accompany the use of each method and adherence monitoring in general as it is used in clinical research. Keywords: compliance, stealth monitoring, deception, adherence monitoring https://www.dovepress.com/ethical-considerations-in-adherence-research-peer-reviewed-article-PPAcompliancestealth monitoringdeceptionadherence monitoring
collection DOAJ
language English
format Article
sources DOAJ
author Patel NU
Moore BA
Craver RF
Feldman SR
spellingShingle Patel NU
Moore BA
Craver RF
Feldman SR
Ethical considerations in adherence research
Patient Preference and Adherence
compliance
stealth monitoring
deception
adherence monitoring
author_facet Patel NU
Moore BA
Craver RF
Feldman SR
author_sort Patel NU
title Ethical considerations in adherence research
title_short Ethical considerations in adherence research
title_full Ethical considerations in adherence research
title_fullStr Ethical considerations in adherence research
title_full_unstemmed Ethical considerations in adherence research
title_sort ethical considerations in adherence research
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2016-12-01
description Nupur U Patel,1 Blake A Moore,1 Rebekah F Craver,2 Steven R Feldman1,2 1Department of Dermatology, Center for Dermatology Research, 2Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA Abstract: Poor adherence to treatment is a common cause of medical treatment failure. Studying adherence is complicated by the potential for the study environment to impact adherence behavior. Studies performed without informing patients about adherence monitoring must balance the risks of deception against the potential benefits of the knowledge to be gained. Ethically monitoring a patient’s adherence to a treatment plan without full disclosure of the monitoring plan requires protecting the patient’s rights and upholding the fiduciary obligations of the investigator. Adherence monitoring can utilize different levels of deception varying from stealth monitoring, debriefing after the study while informing the subject that some information had been withheld in regard to the use of adherence monitoring (withholding), informed consent that discloses some form of adherence monitoring is being used and will be disclosed at the end of the study (authorized deception), and full disclosure. Different approaches offer different benefits and potential pitfalls. The approach used must balance the risk of nondisclosure against the potential for confounding the adherence monitoring data and the potential benefits that adherence monitoring data will have for the research subjects and/or other populations. This commentary aims to define various methods of adherence monitoring and to provide a discussion of the ethical considerations that accompany the use of each method and adherence monitoring in general as it is used in clinical research. Keywords: compliance, stealth monitoring, deception, adherence monitoring 
topic compliance
stealth monitoring
deception
adherence monitoring
url https://www.dovepress.com/ethical-considerations-in-adherence-research-peer-reviewed-article-PPA
work_keys_str_mv AT patelnu ethicalconsiderationsinadherenceresearch
AT mooreba ethicalconsiderationsinadherenceresearch
AT craverrf ethicalconsiderationsinadherenceresearch
AT feldmansr ethicalconsiderationsinadherenceresearch
_version_ 1725745131354587136